Management, LLC, a Delaware limited liability company, indirectly owns 2,188,780 shares of Common Stock because it serves as the investment manager of Sabby Healthcare Master Fund, Ltd. and Sabby Volatility Warrant Master Fund, Ltd., Cayman Islands companies. Mr. Mintz indirectly owns 2,188,780 shares of Common Stock in his capacity as manager of Sabby Management, LLC.
The address for Sabby Healthcare Master Fund, Ltd. and Sabby Volatility Warrant Master Fund, Ltd. is 89 Nexus Way, Camana Bay Grand Cayman KY1-9007 Cayman Islands and for Sabby Management, LLC and Mr. Mintz is 10 Mountainview Road, Suite 205 Upper Saddle River, New Jersey 07458.
(3)
Based solely on the Schedule 13G/A filed on February 16, 2016 by Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LLC and Bihua Chen. As disclosed in the Schedule 13G/A, the shares are held by Cormorant Global Healthcare Master Fund, LP, for which Cormorant Global Healthcare GP, LLC serves as the general partner and Cormorant Asset Management, LLC serves as the investment manager. Bihua Chen serves as the managing member of Cormorant Global Healthcare GP, LLC and Cormorant Asset Management, LLC. Each of the reporting persons has shared voting and investment power over all 1,176,235 shares.
The address for the above entities and person is 200 Claredon Street, 52nd Floor, Boston, Massachusetts 02116.
(4)
Based solely on the Schedule 13G filed on May 18, 2016 by Frigate Ventures LP (“Frigate”), Admiralty Advisors LLC (“Admiralty”), Bruce R. Winson, M5V Advisors Inc. (“M5V”), Adam Spears and Moez Kassam. As disclosed in the Schedule 13G, the shares are held by a private fund to which Frigate and M5V serve as co-investment advisors (the “Fund”). Frigate and M5V serve as co-investment advisors to the Fund and may direct the vote and disposition of the 1,367,988 shares of Common Stock held by the Fund. As the general partner of Frigate, Admiralty may direct the vote and disposition of the 1,367,988 shares of Common Stock held by the Fund. As the principal of Frigate and Admiralty, Mr. Winson may direct the vote and disposition of the 1,367,988 shares of Common Stock held by the Fund. As directors of M5V, Mr. Spears and Mr. Kassam may each direct the vote and disposition of the 1,367,988 shares of Common Stock held by the Fund.
The address for Frigate, Admiralty and Mr. Winson is 5950 Berkshire Lane, Suite 210 Dallas, Texas 75225 and for M5V, Mr. Spears and Mr. Kassam is 111 Peter Street, Suite 904 Toronto, ON M5V 2H1.
(5)
Based solely on the Schedule 13G filed on May 12, 2016 by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (“Intracoastal”, and together with Mr. Kopin and Mr. Asher the “Reporting Persons”). As disclosed in the Schedule 13G, immediately following the execution of the Securities Purchase Agreement between GenVec and the Reporting Persons on May 4, 2016 (the “SPA”) (as disclosed in the Form 8-K filed by the Company with the SEC on May 10, 2016), each of the Reporting Persons may have been deemed to have beneficial ownership of, and shared voting and dispositive power as to, 1,367,989 shares of Common Stock. The foregoing excludes 1,025,992 shares of Common Stock issuable upon exercise of a warrant that was to be issued to Intracoastal at the closing of the transaction contemplated by the SPA (the “Intracoastal Warrant”) because the Intracoastal Warrant is not exercisable until on or after November 10, 2016 (and the Intracoastal Warrant contains a blocker provision under which the holder thereof does not have the right to exercise the Intracoastal Warrant to the extent that such exercise would result in beneficial ownership by the holder thereof, together with the holder’s affiliates and any other persons acting as a group together with the holder or any of the holder’s affiliate, of more than 4.99% of the Common Stock). Without such blocker provision (and assuming that the Intracoastal Warrant was currently exercisable), each of the Reporting Persons may have been deemed to have beneficial ownership of 2,393,981 shares of Common Stock.
As of the close of business on May 12, 2016, each of the Reporting Persons may be deemed to have beneficial ownership of 1,346,799 shares of Common Stock. The foregoing excludes 1,025,992 shares of Common Stock issuable upon exercise of the Intracoastal Warrant because the Intracoastal Warrant is not exercisable until on or after November 10, 2016 (and the Intracoastal Warrant contains a blocker provision under which the holder thereof does not have the right to exercise the Intracoastal